An underlying assumption of these aggregate results is that signaling of the complementary receptor/ligands present on the surface of recipient T cells and carried by TEX drives T cell apoptosis in patients with cancer, as indicated in Fig. 4c. The gene discussed is TEX46; the disease is cancer.